2003 |
nisin A (3 kDa) |
PEG (5 kDa) |
Long PEG chain reduced AMP bactericidal activity and toxicity |
44
|
2007 |
tachyplesin I (2.3 kDa) |
PEG (5 kDa) |
Long PEG chain reduced AMP bactericidal activity and toxicity |
116
|
2007 |
magainin 2 (2.5 kDa) |
PEG (5 kDa) |
Long PEG chain reduced AMP bactericidal activity and toxicity |
115
|
2008 |
MA (1.6 kDa) |
PEG (0.75 and 1.1 kDa) |
Decreasing PEG length improved bactericidal activity, but increased toxicity |
118
|
2012 |
CaLL (2.8 kDa) |
PEG (0.67 and 1 kDa) |
Conjugation improved cytocompatibility; decreasing PEG length increased conjugate bactericidal activity |
117
|
2014 |
poly(lysine-co-phenylalanine) (varied from 5.5 to 0.5 kDa) |
PEG (5 and 2 kDa) |
Decreasing PEG length improved conjugate bactericidal activity, but increased toxicity |
57
|
2017 |
Peptide 77c (1.8 kDa) |
PEG (5 kDa) |
Conjugation to PEG reduced bactericidal activity |
37
|
2020 |
cryptdin-2 (4.7 kDa) |
PEG (5 kDa) |
Conjugates retained bactericidal activity, reduced toxicity, and improved stability of AMP in murine serum |
39
|